ENO1 and cancer: Although increased angiogenesis is a hallmark of cancer [35], the early pre-leukemic changes are characterized by reduced number of EC, reduced VEGFR1, and -2 signaling, and increased expression of the HIF-1α target genes Pgk1- and Eno1 by CD31+ CD45- Ter119- cells.